J. A. Wedzicha (London, United Kingdom), S. L. Johnston (London, United Kingdom)
The impact of pseudomonas aeruginosa in the sputum of patients presenting with acute COPD exacerbation
A. C. Elliott, C. Bassett, A. L. Pilling, R. J. Wolstenholme (Wigan, United Kingdom)
|   |
Differential inflammatory effects of colonising airway bacteria in COPD
T. Wilkinson, D. Powrie, M. Wilks, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Short-term recovery in SGRQ following a COPD exacerbation in the MOSAIC study correlates with the preceding deterioration, but is larger
P. W. Jones, S. Spencer, I. Duprat-Lomon, P. P. Sagnier, R. Wilson (London, Uxbridge, United Kingdom; Puteaux, France)
| |
Relationships between the common cold and exacerbation frequency in COPD
J. R. Hurst, G. C. Donaldson, T. M. A. Wilkinson, W. R. Perera, J. A. Wedzicha (London, United Kingdom)
| |
An experimental model of rhinovirus-induced COPD exacerbation
P. Mallia, T. Kebadze, S. Message, S. Johnston (London, United Kingdom)
| |
Circulating respiratory syncytial virus-specific CD8+ T cells are present in a low frequency in healthy individuals and patients with COPD
G. J. De Bree, J. Heidema, R. E. Jonkers, H. Korse, R. A. van Lier, H. M. Jansen, T. A. Out (Amsterdam, Utrecht, The Netherlands)
| |
Effects of RSV-infection on the cytokine-profile of T-lymphocytes from COPD patients
J. Kronsbein, M. Kauth, A. Wiethege, G. Schultze-Werninghaus, G. Rohde (Bochum, Germany)
| |
Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum
A. Strassburg, A. Niederfahrenhorst, A. Luers, K. Dalhoff (Luebeck, Germany)
| |